Home ›Top Stories ›Serum gets DCGI nod for Phase 2 & 3 trials
MASIGNASUKAv102
6510051498749449419

Serum gets DCGI nod for Phase 2 & 3 trials

Serum gets DCGI nod for Phase 2 & 3 trials
India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.

from Times of India https://ift.tt/2Xp9JnX
Ankkit

Related Post

comment 0 Comments

more_vert

:)
:(
hihi
:-)
:D
=D
:-d
;(
;-(
@-)
:P
:o
-_-
(o)
[-(
:-?
(p)
:-s
(m)
8-)
:-t
:-b
b-(
:-#
=p~
$-)
(y)
(f)
x-)
(k)
(h)
(c)
cheer
(li)
(pl)
Emoticon Feedback